title: Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage.
abstract: A prospective randomized pilot study of subcutaneous low-dose heparin in the prevention of deep-vein thrombosis and pulmonary embolism was carried out in patients admitted to hospital after intracerebral hemorrhage. A high incidence of deep-vein thrombosis and lung embolism was detected by phleboscintigraphy and lung perfusion scintigraphy, respectively. There was no significant reduction of deep-vein thrombosis and pulmonary embolism in the therapy group. Heparin did not increase the risk of rebleeding.
authors.affiliation: Neurologische Klinik, Universität Göttingen.
authors.forename: U
authors.initials: U
authors.lastname: Dickmann
authors.forename: E
authors.initials: E
authors.lastname: Voth
authors.forename: H
authors.initials: H
authors.lastname: Schicha
authors.forename: T
authors.initials: T
authors.lastname: Henze
authors.forename: H
authors.initials: H
authors.lastname: Prange
authors.forename: D
authors.initials: D
authors.lastname: Emrich
mesh_terms: D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000150:complications*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000517:prevention & control*; D012008:Recurrence; D013924:Thrombophlebitis / Q000517:prevention & control*
chemical_list: D006493:Heparin